ArticleCJC open2026
Current Practice Patterns and Barriers to Intravascular Imaging-Guided Percutaneous Interventions: Insights from a Canadian Nationwide Survey.
Article in CJC open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite robust evidence supporting use of intravascular imaging (IVI) to guide complex percutaneous coronary intervention (PCI), its adoption across Canada remains poorly defined. Methods: A standardized cross-sectional electronic survey was distributed to catheterization laboratory directors across Canada. Results: Sites were evenly distributed between academic (9; 43%) and nonacademic (12; 57%) institutions, with a mean annual PCI volume of 1706 ± 722 procedures. IVI integration into the catheterization laboratory was reported in 38 of 56 laboratories (68%), with a median of 6 PCI operators (interquartile range, 5-9) per site. Operator comfort levels were generally good, with the majority of catheterization laboratory directors describing their operators as being somewhat experienced (6; 29%) or very experienced (9; 43%). Most directors (90%) perceived IVI as having a positive impact on outcomes. Overall, results showed a trend toward an increase in IVI-guided PCI between 2022 and 2024 (15.6% vs 19.1%, Conclusions: Although IVI is widely available in Canadian catheterization laboratories, it remains underused, due to barriers related to procedure time, workflow, and cost. A coordinated effort among key stakeholders is needed to reduce current barriers and promote broader guideline-concordant use and IVI adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.